Which medications, tests, and treatments should you really get? Recommendations for “Choosing Wisely”

Jennifer Yttri, PhD August 2013   When it comes to our health we often want to know as much as possible. But sometimes there is just too much information on what to do to stay healthy. We get advertisements on … Continue reading

NRC and Patient, Consumer, and Public Health Coalition comments to FDA: Don’t need a new pathway for antibiotics for limited populations!

The FDA considered a new way to approve drugs for use in small patient populations. NRC warn that such a pathway would put patients at risk of harm by giving them poorly studied drugs without knowing if the drugs provide any benefit. Continue reading

Testimony of Dr. Jennifer Yttri on Bedaquiline

Dr. Yttri testifies to the FDA Committee that the data on bedaquiline indicate that the benefit to patients with multi drug resistant tuberculosis is questionable. The FDA’s responsibility is to approve drugs that will help, not harm, consumers. Treatments exist for patients with multi drug resistant tuberculosis that are safer without the addition of bedaquiline. Continue reading

Statement from Dr. Jennifer Yttri, senior fellow, at the FDA Public Hearing Establishing a List of Qualifying Pathogens for the GAIN Act

Dr. Yttri testifies to the FDA that the growing risk of antibiotic resistant pathogens and need for development and responsible use of new antibiotics are critical public health concerns that need to be addressed. Continue reading

Pancreatic Cancer: Could Bacteria in our Mouth Help us Detect this Deadly Cancer Sooner?

Pancreatic cancer has an extremely low survival rate because it is difficult to detect at early stages. A method for earlier diagnosis would greatly improve patients’ chances of survival. New research suggests that a specific type of oral bacteria might serve as a warning sign for pancreatic cancer. Continue reading

Some Antibiotics Are Riskier Than Others: What You Should Know About Quinolones

Even when there is a bacterial infection, antibiotics should be chosen with care to ensure that patients receive the antibiotic that is most effective for their specific condition and comes with the fewest risks. Just as penicillins are best for syphilis and macrolides for tonsillitis, quinolones are only preferred for treating certain types of bacterial infections, such as pneumonia, urinary tract infections, and some skin infections. Even for patients over 60 with any of these conditions, other antibiotics may be a safer option. Continue reading